| AMD1P2 |
|
adenosylmethionine decarboxylase 1 pseudogene 2
|
|
|
0.608 |
0.538 |
| CCT |
|
cataract, congenital, total
|
|
|
0.588 |
0.769 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| CNC2 |
|
Carney complex type 2, multiple neoplasia and lentiginosis
|
|
|
0.674 |
0.692 |
| EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
| FSHMD1A |
|
facioscapulohumeral muscular dystrophy 1A
|
|
|
0.638 |
0.808 |
| GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
| MS |
|
multiple sclerosis
|
|
|
0.599 |
0.692 |
| PRD |
|
primary retinal dysplasia
|
|
|
0.821 |
0.231 |
| PRS |
|
Prieto X-linked mental retardation syndrome
|
|
|
0.663 |
0.615 |
| TRD |
|
T cell receptor delta locus
|
|
|
0.650 |
0.692 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| GHS |
|
Goldenhar syndrome
|
|
|
0.659 |
0.615 |
| ERDA1 |
|
expanded repeat domain, CAG/CTG 1
|
|
|
0.736 |
0.154 |
| LILRB2 |
|
leukocyte immunoglobulin like receptor B2
|
|
1.3E-14 |
0.623 |
0.615 |
| DISC2 |
|
disrupted in schizophrenia 2
|
|
|
0.716 |
0.192 |
| EPB41L4A-DT |
|
EPB41L4A divergent transcript
|
|
|
0.736 |
0.308 |
| GER |
|
Gastroesophageal reflux
|
|
|
0.678 |
0.538 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| RSS |
|
Russell Silver syndrome
|
|
|
0.578 |
0.692 |
| CACNA1G-AS1 |
|
CACNA1G antisense RNA 1
|
|
|
0.736 |
0.346 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| DAOA-AS1 |
|
DAOA antisense RNA 1
|
|
|
0.729 |
0.154 |
| HCCAT5 |
|
hepatocellular carcinoma associated transcript 5
|
|
|
0.716 |
0.462 |